During this calendar year the share price has gone from 4.5c to 0.6c - a capital loss of 86.67%
During this same period the company has 'lost' one of it's "fantastic" deals in somewhat confusing circumstances. Anyone care to wager whether Balam ends up with that tech, somehow...?
Then it 'sold' another of it's technologies to a related entity for a 'book profit' but that has proved to have little substance to date.
Now funding for BreatheAssist has gone down the tubes and the company is just about out of money.
So, what are we left with Vibrovein, which is some years off commercialisation and BreatheAssist that is looking to get out of the blocks, but seems to be struggling.
Have I forgotten any other "amazing" deals FB and his team have rolled out.
Also during this time, where the sp has lost most of it's value and no deals of substance have been done, the company has spent nearly $5m on lavish travel and huge salaries on an extraordinarily large team.
In recent days we have seen a mea culpa or two with FP's salary cut in half, etc... but what on earth is going on here?
Where are they going to get income from to cover costs...? They're not. So, where does the cash come from? Share dilution, AGAIN? Probably, but shareholders are going to get sick of this and there isn't that much of value in the business, so again, what on earth is going on in this company..?
CGP Price at posting:
3.0¢ Sentiment: LT Sell Disclosure: Held